About 8 results found for searched term "91-92-9" (0.095 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7936 | Mephetyl tetrazole | Potassium Channel |
| Mephetyl tetrazole is a potent, selective Kv1.5 potassium channel blocker with an IC50 value of 330 nM that selectively prolongs atrial effective response period (ERP) but has no effect on ventricular ERP. | ||
| M30912 | Ro 25-6981 hydrochloride | GluR |
| Ro 25-6981 hydrochloride is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 hydrochloride shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 hydrochloride has the potential for the research of parkinson's disease (PD). | ||
| M43599 | ER degrader 4 | Estrogen Receptor |
| ER degrader 4 is a selective and orally active estrogen receptor degrader. | ||
| M44761 | Acanthopanaxoside B | Others |
| Acanthopanaxoside B is a triterpenoid saponin isolated from the leaves of Acanthopanax senticosus. | ||
| M49508 | LRRK2/NUAK1/TYK2-IN-1 | LRRK2 |
| LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM. | ||
| M55405 | Adenophostin A | Others |
| AdA; Adenophostin | ||
| Adenophostin A is a potent agonist of inositol 1,4,5-trisphosphate receptors (IP(3) R). Adenophostin A possesses the highest known affinity for the inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) receptor (InsP3R). In high concentrations, adenophostin A released Ca2+ from Ins(1,4, 5)P3-sensitive stores and stimulated a Cl- current that depended upon the presence of extracellular Ca2+. | ||
| M57239 | Lubabegron fumarate | Androgen Receptor |
| Lubabegron (LY-488756) fumarate is an antagonist of the adrenergic receptor (β-AR). | ||
| M56738 | Naphthol AS-BR | Phosphatase |
| Naphthol AS-BR is a substrate for the histochemical demonstration of acid and alkaline phosphatase. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
